Mild to moderate substance misuse and depression Mental and Behavioural Disorders Depressive episode, unspecified
Conditions
Interventions
Comparing behavioural activation with a minimal treatment intervention (1 session self-help and bibliotherapy)
Behavioural Activation (BA) is a structured psychological intervention for depression ba
Hopko et al., 2003). Essentially, it consists of:
1. Self-monitoring to identify depressive and maladaptive behaviours
2. Scheduling activities aiming to reinforce adaptive behaviour patterns
3. Redu
in addition the research team will organise a full-day training event to orientate therapists to this
Sponsors
NHS Leeds (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Are currently engaging with a community drugs treatment, detox, maintenance or addiction recovery focused service in Leeds. Engagement is defined by: 1.1. Being currently registered with a formal addiction focused service or programme 1.2. Having had planned contact with the service within the last month 2. Meet criteria for a current depressive disorder as defined by a score of 12 or more on the PHQ-9 questionniare. Comorbid anxiety disorders are not exclusion criteria, as long as depression is the primary disorder 3. Meet criteria for mild-to-moderate severity of drug dependence, as defined by a score between 0 ? 10 on the Severity of Dependence Questionnaire 4. Have used alcohol, drugs, or methadone maintenance medication within the last month
Exclusion criteria
Exclusion criteria: 1. Are not currently engaging in a formal addiction treatment or support programme in Leeds 2. Do not currently meet criteria as clinically significant for depressive disorder as defined by the PHQ-9 questionnaire score 3. Meet criteria for depression and a comorbid anxiety disorder, as identified by the GAD-7 questionnaire. Where the anxiety disorder is more severe, has been of longer duration than depressive symptoms and is the patient's main concern. 4. Meet criteria for a severe mental disorder including bipolar affective disorder, schizophrenia or other psychotic disorders. Patients with severe mental health problems who are already involved in psychiatric or secondary care mental health services. 5. Are free of substances of dependence and/or maintained on disulfiram, acamprosate or naloxone. 6. Those who have a severe drug or alcohol dependence, as defined by a score above 10 on the Severity of Dependence Questionnaire.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patient Health Questionnaire (PHQ-9) Measured at baseline, then 6 weeks post therapy and 12 weeks post therapy. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Generalised Anxiety Disorder (GAD-7) 2. Treatment Outcomes Profile (TOP) 3. Substance misuse section of PRISM Measured at baseline, then 6 weeks post therapy and 12 weeks post therapy. | — |
Countries
United Kingdom
Outcome results
None listed